CD274 and neoplasm: Beyond direct oncogenic signaling, activated FGFR pathways contribute to an immunosuppressive TME by upregulating immune checkpoint molecules such as PD-L1, suppressing T-cell function, and promoting tumor-associated macrophage polarization.